Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CASTLE BIOSCIENCES INC Director's Dealing 2021

Aug 6, 2021

32601_dirs_2021-08-06_a0a7e8c7-4363-4ea9-973a-dc82c152e682.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-08-03

Reporting Person: BRADBURY DANIEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-03 Common Stock S 1400 $68.626 Disposed 279593 Indirect
2021-08-03 Common Stock S 1100 $69.48 Disposed 278493 Indirect
2021-08-03 Common Stock S 1250 $70.071 Disposed 151531 Indirect
2021-08-03 Common Stock S 1250 $70.396 Disposed 151554 Indirect
2021-08-04 Common Stock S 1000 $69.575 Disposed 277493 Indirect
2021-08-04 Common Stock S 1100 $70.662 Disposed 276393 Indirect
2021-08-04 Common Stock S 400 $71.418 Disposed 275993 Indirect
2021-08-04 Common Stock S 1250 $69.137 Disposed 150281 Indirect
2021-08-04 Common Stock S 1250 $69.078 Disposed 150304 Indirect

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on May 26, 2021.

F2: This transaction was executed in multiple trades at prices ranging from $68.020 to $69.000, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.

F4: This transaction was executed in multiple trades at prices ranging from $69.060 to $69.910, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $69.760 to $70.390, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

F7: This transaction was executed in multiple trades at prices ranging from $70.060 to $70.555, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F8: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.

F9: This transaction was executed in multiple trades at prices ranging from $69.200 to $70.050, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F10: This transaction was executed in multiple trades at prices ranging from $70.230 to $71.160, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F11: This transaction was executed in multiple trades at prices ranging from $71.270 to $71.590, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F12: This transaction was executed in multiple trades at prices ranging from $68.640 to $69.490, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F13: This transaction was executed in multiple trades at prices ranging from $68.780 to $69.400, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.